Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

531 ARTÍCULOS , VIENDO DEL 331 AL 345

Efficacy and safety of DaxibotulinumtoxinA for injection in adults with cervical dystonia: Pooled global analysis of ASPEN-1 and ASPEN-1-CN randomized trials

Ellenbogen A, Xingyue H, Lingjing J, Banach M, Patel AT, Gross TM, Kazerooni R, Gallagher CJ, Xiaojing F, Wang H, Lei G, Xinhua W, Hollander DA.

Parkinsonism Relat Disord. 2025 Nov;140:108015. doi: 10.1016/j.parkreldis.2025.108015. Epub 2025 Sep 2.

SCN3A-related neurodevelopmental disorder: Clinical case reports and biophysical characterization

Ghovanloo MR, Gershome C, van der Lee R, Drogemoller B, Zhang L, Matthews A, Blydt-Hansen I, Nikkel SM, Demos M, Wasserman WW, Ross CJ, van Karnebeek CD, Ruben PC.

Channels (Austin). 2025 Dec;19(1):2580175. doi: 10.1080/19336950.2025.2580175. Epub 2025 Oct 30.

Conservative iron chelation for VAC14: Two-year clinical-radiological follow-up

Ollivier T, Devos D, Kuchcinski G, Defebvre L, Huin V, Mutez E.

J Parkinsons Dis. 2025 Jun;15(4):925-928. doi: 10.1177/1877718X251331820. Epub 2025 Apr 13.

Focal dystonia attributed to secondary Nigrostriatal pathway disruption following brainstem Hemorrhage: a case report

Zhou L, Zhao C, Sun Z, Man X, Xiang Y.

Oxf Med Case Reports. 2025 Nov 26;2025(11):omaf210. doi: 10.1093/omcr/omaf210. eCollection 2025 Nov.

Effect of Botulinum Toxin on Sensori-Motor Integration in Movement Disorders: A Scoping Review

Das A, Jog M.

Toxins (Basel). 2025 Aug 16;17(8):416. doi: 10.3390/toxins17080416.

Deep Brain Stimulation: Psychological and Neuroethical Perspectives

Sremic S, Krsek A, Baticic L.

Neurol Int. 2025 Oct 2;17(10):158. doi: 10.3390/neurolint17100158.

Oscillatory dynamics in isolated dystonia: five hundred hours of chronic invasive multisite motor network recordings

Cernera S, Shcherbakova M, Hammer LH, Friedrich M, Peach R, Ip CW, Bledsoe I, Little S, Starr PA.

J Neurophysiol. 2025 Aug 1;134(2):677-690. doi: 10.1152/jn.00198.2025. Epub 2025 Jul 28.

Germline mosaicism in TCF20-associated neurodevelopmental disorders: a case study and literature review

Poquérusse J, Whitford W, Taylor J, Gregersen N, Love DR, Tsang B, Drake KM, Snell RG, Lehnert K, Jacobsen JC.

J Hum Genet. 2025 Apr;70(4):215-222. doi: 10.1038/s10038-025-01323-3. Epub 2025 Feb 26.

Subthalamic nucleus versus globus pallidus internus deep brain stimulation in the treatment of dystonia: A systematic review and meta-analysis of safety and efficacy

Yousef O, Abbas A, Abdelmeseh M, Qafesha RM, Nabil Y, Elrosasy A, Negida A, Berman BD.

J Clin Neurosci. 2025 Feb;132:110958. doi: 10.1016/j.jocn.2024.110958. Epub 2024 Dec 7.

Dopa-responsive dystonia and phenotypes associated with TH gene variants: a systematic review and Mexican case series

Lopez-Urias CU, Monroy-Jaramillo N, Barreda Fierro R, Ramírez-García MÁ.

Neurol Sci. 2025 Sep;46(9):4181-4192. doi: 10.1007/s10072-025-08246-z. Epub 2025 May 29.

Genome writing to dissect consequences of SVA retrotransposon disease X-Linked Dystonia Parkinsonism

Zhang W, Zhao Y, Prakash P, Appleby HL, Barriball K, Capponi S, Jiang Q, Wudzinska AM, Vaine CA, Ellis G, Rahman N, Markovic S, Mishkit O, Limberg KC, Maurano MT, Wadghiri YZ, Kim SY, Timmers HTM, Bragg DC, Liddelow SA, Brosh R, Boeke JD.

bioRxiv [Preprint]. 2025 Oct 8:2025.10.07.680816. doi: 10.1101/2025.10.07.680816.

Deep brain stimulation for Meige syndrome

Jaffee S, Hussain S, Spott M, Kite TS, Tomycz N.

Surg Neurol Int. 2025 Aug 22;16:355. doi: 10.25259/SNI_1018_2024. eCollection 2025.

Long-Term Safety and Efficacy of Repeat Treatments with DaxibotulinumtoxinA in Cervical Dystonia: Results from the ASPEN-Open-Label Study

McAllister P, Patel AT, Banach M, Ellenbogen A, Slawek J, Paus S, Jinnah HA, Evidente V, Gross TM, Kazerooni R, Gallagher CJ, Hollander DA.

Mov Disord Clin Pract. 2025 Nov;12(11):1764-1773. doi: 10.1002/mdc3.70104. Epub 2025 May 29.

Myelin pathology is a key feature of X-linked Dystonia Parkinsonism

Prakash P, Limberg KC, Zhang W, Zhao Y, Laborc KF, O'Keeffe A, Vilnaigre BC, Appleby H, O'Dea MR, Fernandez-Cerado C, Legarda GPA, Sy M, Muñoz EL, Ang MAC, Diesta CCE, Han J, Norenberg E, Penney EB, Bragg DC, Mar AC, Brosh R, Boeke JD, Liddelow SA.

bioRxiv [Preprint]. 2025 Oct 8:2025.10.07.680990. doi: 10.1101/2025.10.07.680990.

Duloxetine-associated parkinsonism in a patient with subclinical parkinson's disease: a case report

Yamada G, Toyoda T, Kuno T, Okita K, Katada E, Matsukawa N.

Neurol Sci. 2025 May;46(5):2293-2296. doi: 10.1007/s10072-025-08052-7.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias